Christian Rolfo: Important meeting on Drug Tolerance and Resistance in NSCLC
Christian Rolfo, Associate Director of Clinical Research Center of Thoracic Oncology at The Tisch Cancer Institute at Mount Sinai Health System, shared the following post by International Association for the Study of Lung Cancer (IASLC) on X, adding the following:
“Important meeting on Drug Tolerance and Resistance in NSCLC. Please submit your abstract! Great opportunity to discuss on translational research. See you all in Washington DC!”
Quoting International Association for the Study of Lung Cancer (IASLC)’s post:
“Deadline Extended! Submit your abstract to dive deep into the mechanisms, biomarkers & models that drive our understanding/treatment of drug tolerance/resistance in NSCLC. Share your groundbreaking research. Contribute to the future of lung cancer therapy.”
Source: Christian Rolfo/X and IASLC/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023